Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol
- PMID: 9968
- PMCID: PMC1428931
- DOI: 10.1111/j.1365-2125.1976.tb00637.x
Assessment of alpha- and beta-adrenoceptor blocking actions of labetalol
Abstract
Isoprenaline dose-response curves plotting increases in heart rate before and after labetalol are suggestive of competitive antagonism at beta-adrenoceptor sites. Phenylephrine dose-response curves using increases in systolic pressure before and after labetalol are suggestive of competitive antagonism at alpha-adrenoceptor sites. The ratio of alpha:beta-adrenoceptor antagonism induced by labetalol is approximately 1:3. Peak pharmacological responses after a single oral dose of labetalol (400 mg) occurred between 90-120 min after administration.
Similar articles
-
Pharmacological basis for antihypertensive effects of intravenous labetalol.Br Heart J. 1977 Jan;39(1):99-106. doi: 10.1136/hrt.39.1.99. Br Heart J. 1977. PMID: 12778 Free PMC article.
-
Comparison of medroxalol and labetalol, drugs with combined alpha- and beta-adrenoceptor antagonist properties.Br J Clin Pharmacol. 1984 May;17(5):565-72. doi: 10.1111/j.1365-2125.1984.tb02391.x. Br J Clin Pharmacol. 1984. PMID: 6145440 Free PMC article.
-
The relationships between the cardiovascular effects, alpha- and beta-adrenoceptor blocking actions and plasma concentration of labetalol in doca hypertensive rats.Clin Exp Hypertens (1978). 1979;1(5):597-611. doi: 10.3109/10641967909068627. Clin Exp Hypertens (1978). 1979. PMID: 42517
-
A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):681-4. Br J Clin Pharmacol. 1976. PMID: 10948 Review.
-
Pharmacological effects of labetalol in man.Br J Clin Pharmacol. 1976 Aug;3(4 Suppl 3):721-3. Br J Clin Pharmacol. 1976. PMID: 10949 Review.
Cited by
-
Changes in heart rate and forearm blood flow following intravenous boluses of isoprenaline in the presence of practolol and propranolol.Br J Clin Pharmacol. 1983 Jan;15(1):37-40. doi: 10.1111/j.1365-2125.1983.tb01460.x. Br J Clin Pharmacol. 1983. PMID: 6849742 Free PMC article. Clinical Trial.
-
Retrospective evaluation of labetalol as antihypertensive agent in dogs.BMC Vet Res. 2020 Jul 24;16(1):256. doi: 10.1186/s12917-020-02475-4. BMC Vet Res. 2020. PMID: 32709242 Free PMC article.
-
Effect of labetalol in hypertension during exercise and postural changes.Br J Clin Pharmacol. 1979;8(Suppl 2):95S-100S. Br J Clin Pharmacol. 1979. PMID: 526410 Free PMC article.
-
Impact of Antihypertensive Treatment on Maternal and Perinatal Outcomes in Pregnancy Complicated by Chronic Hypertension: A Systematic Review and Meta-Analysis.J Am Heart Assoc. 2017 May 17;6(5):e005526. doi: 10.1161/JAHA.117.005526. J Am Heart Assoc. 2017. PMID: 28515115 Free PMC article.
-
A comparison of the effects of labetalol, bendrofluazide and their combination in hypertension.Br J Clin Pharmacol. 1979 Aug;8(2):149-54. doi: 10.1111/j.1365-2125.1979.tb05813.x. Br J Clin Pharmacol. 1979. PMID: 385023 Free PMC article. Clinical Trial.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources